[1]
Kachhadia, M.P. et al. 2026. Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: Current Evidence and Emerging Strategies. Journal of Clinical Medicine Research. 18, 7 (Jan. 2026), 421–436. DOI:https://doi.org/10.14740/jocmr6603.